List of Pharma Express

Pharma Express	N°393	Nouvelle convention pharmaceutique : Quel impact pour les industriels ?	04/11/12
Pharma Express	N°392	Décrets Loi Bertrand et LFSS : Des zones d'ombre persistent	04/03/12
Pharma Express	N°391	Rapport controversé de l'Académie de médecine sur les génériques	03/02/12
Pharma Express	N°390	Pharma Express n°390 : La simplification du cadre des essais cliniques enfin adoptée !	02/24/12
Pharma Express	N°389	Un CSIS sans Président mais pas sans ambition	01/27/12
Pharma Express	N°370	PPL Fourcade : Rappel à l'ordre du Conseil constitutionnel	08/25/11
Pharma Express	N°362	Médiator : un rapport IGAS radical, qui tranche notamment avec celui de l'Assemblée	06/22/11
Pharma Express	N°361	Assises du médicament ou cour d'assise ?	06/09/11
Pharma Express	N°360	PPL Fourcade : Les parlementaires déjà en ordre de bataille sur le médicament	05/25/11
Pharma Express	N°359	Le nouveau président de la HAS concède la nécessité de réformer la commission de la transparence	05/03/11
Pharma Express	N°358	Rigueur en perspective sur la maîtrise des comptes	04/21/11
Pharma Express	N°354	Assises et nouvelle gouvernance du médicament : le challenge pour l'industrie sera de faire entendre sa voix	02/18/11
Pharma Express	N°353	Mediator, une affaire aux mutliples conséquences	01/27/11
Pharma Express	N°352	2011, l'année de tous les dangers pour le secteur pharmaceutique ?	01/17/11
Pharma Express	N°351	Expansive hospital drugs under monitoring	12/07/10
Pharma Express	N°350	La CMP a (un peu) débattu des orphelins	11/18/10
Pharma Express	N°349	Un nouveau Gouvernement en plein PLFSS	11/15/10
Pharma Express	N°348	PLFSS : Au Sénat, le Gouvernement impose ses vues sur la fiscalité des médicaments et la médico-économie	11/12/10
Pharma Express	N°347	PLFSS : La Commission met les orphelins et la médico-économie au menu du Sénat	11/04/10
Pharma Express	N°346	PLFSS : Contournement pas à pas de la notion d'équivalents thérapeutiques	10/29/10
Pharma Express	N°333	€ 100 million price cuts despite any setting off from the Alert Committee on Healthcare spendings	06/01/10
Pharma Express	N°332	Pharma Express n°332 : L'arbitrage UNCAM/médecins engendre de nouvelles économies sur le médicament	05/07/10
Pharma Express	N°331	French Health Body HAS wants to reinforce constraints on hospital medical representative’s visit	04/29/10
Pharma Express	N°330	European Court's decision should preserve French individual contracts for doctors	04/23/10
Pharma Express	N°329	2nd Marescaux Report: opportunities for pharmaceutical industry?	04/14/10
Pharma Express	N°328	French public sick-fund CNAMTS prepares the future regulation	04/08/10
Pharma Express	N°327	Trends regarding French regulation on health products regulation	03/19/10
Pharma Express	N°326	French left-wing thinks bets on strong industry policy too	03/02/10
Pharma Express	N°325	Reimbursement rate at 15% progressively put in place	02/18/10
Pharma Express	N°324	Flash : Le "dual-pricing" voted by the French National Assembly for the second time	02/18/10
Pharma Express	N°323	Working groups on the industry : the Belingard report's findings	01/15/10
Pharma Express	N°322	Issues in 2010 concerning medicine and health	01/08/10
Pharma Express	N°321	2010 Social Security Financing Bill: The Supreme Court invalidates the measures on dual-pricing and on the wider definition of generics	12/23/09
Pharma Express	N°320	Finally, no measure on drugs with same therapeutic goal in the French Social Security Financing Bill	11/19/09
Pharma Express	N°319	PLFSS 2010 : la CMP devra trancher sur les médicaments à même visée thérapeutique	11/16/09
Pharma Express	N°318	PLFSS 2010 : Après le vote du Sénat, le «K» va rester à 1%	11/13/09
Pharma Express	N°317	La Commission des affaires sociales sanctionne le flou sur les modalités de substitution entre médicaments à même visée thérapeutique	11/06/09
Pharma Express	N°316	Bachelot invoque l'équilibre budgétaire pour rebaisser le «K»	11/02/09
Pharma Express	N°315	PLFSS 2010 : L'Assemblée resserre l'étau sur la propriété intellectuelle et les équivalents thérapeutiques	10/30/09
Pharma Express	N°314	2010 Social Security Financing Bill : Controversy over measures supporting the pharmaceutical industry	10/29/09
Pharma Express	N°313	Le Président donne une nouvelle envergure au CSIS	10/27/09
Pharma Express	N°312	PLFSS 2010 : Les amendements adoptés en commissions	10/23/09
Pharma Express	N°311	PLFSS 2010 : Le «K» à 1% et 460 M€ de baisses de prix	10/02/09
Pharma Express	N°310	Que faut-il attendre du PLFSS et du CSIS ?	09/24/09
Pharma Express	N°309	Rapport du CEPS : la priorité aux baisses de prix	07/31/09
Pharma Express	N°308	La VM hospitalière moins contrainte que prévue	07/29/09
Pharma Express	N°307	HPST: Le Conseil constitutionnel valide l'éducation thérapeutique mais…	07/17/09
Pharma Express	N°306	PLFSS 2010 : Le coup d'envoi est donné par la CNAM	07/10/09
Pharma Express	N°305	Enquête sectorielle : La Commission européenne ne lache pas	07/09/09
Pharma Express	N°304	HPST: La CMP entérine le texte du Sénat sur l'éducation thérapeutique	06/17/09
Pharma Express	N°303	Education thérapeutique : le Sénat propulse la HAS au cœur du dispositif	06/05/09
Pharma Express	N°302	Marescaux Report : political will or alibi ?	05/13/09
Pharma Express	N°301	HPST on Senate : Social Affairs Commission clarifies industry's part on therapeutical education	05/06/09
Pharma Express	N°300	Launch of the Individual Contracts between Doctors and National Sick Fund : quo vadis ?	04/22/09
Pharma Express	N°299	Hospital : regulation is accelerated	03/30/09
Pharma Express	N°298	HPST - Will the education or the accompaniment of the patient take place without the industry ?	03/06/09
Pharma Express	N°297	HPST : Hospital drugs purchasing policy introduced in the debate	02/17/09
Pharma Express	N°296	HPST : Expected confrontationn on the therapeutic education	02/10/09
Pharma Express	N°295	On crisis situation, public bodies want to bet on research and innovation	01/27/09
Pharma Express	N°294	Pharma : 2008 Sum up and 2009 Expectations	01/14/09
Pharma Express	N°293	Pharmaceutical package : few surprises after refereeing	12/11/08
Pharma Express	N°292	Report on long duration affections : a new deal ?	12/03/08
Pharma Express	N°291	Social Security Financing Bill 2009 : After the mixed Commission (National Assembly / Senate), reserved assessment for the industry	11/27/08
Pharma Express	N°290	Social Security Financing Bill : The Government strengthens a little extension of the generic drugs list	11/20/08
Pharma Express	N°289	Social Security Financing Bill : The Senators mistake continued existence on taxes for prevision	11/14/08
Pharma Express	N°288	The Senators knock down the National Assembly decisions on drugs	11/07/08
Pharma Express	N°287	Social Security Financing Bill : Agreement of annual cuts on prices for innovative drugs, thanks to the socialist party	10/31/08
Pharma Express	N°286	Social Security Financing Bill 2009 : Deputies heard sector difficulties	10/30/08
Pharma Express	N°285	Invitation to tender and generic drugs list extension : Social Affairs Commission hardens the sound of the Social Security Financing Bill	10/24/08
Pharma Express	N°283	Agreements fusion : hospital will be more expensive	10/24/08
Pharma Express	N°284	Social Security Financing Bill : Behind appearances, the pharmaceutical industry still have to pay	10/01/08
Pharma Express	N°282	Healthcare Reform : Time bomb for the President	09/23/08
Pharma Express	N°281	Social Security Financing Bill : On the way to closed enveloppes for non-important and costly hospital products	09/09/08
Pharma Express	N°280	First project of the Healthcare Reform Bill	09/03/08
Pharma Express	N°279	Committee for Pricing and Reimbursement of Healthcare Products' Report : the commitee leaves its territory	08/01/08
Pharma Express	N°278	Signature of the Hospital Charter for Medical Reps : a minimalist extension	07/25/08
Pharma Express	N°277	For the French senators, specific regulation and tax harm pharmaceutical innovation and competitiveness	07/24/08
Pharma Express	N°276	Public sick-funds saving plan : jumbo-groups are not far	06/24/08
Pharma Express	N°275	French MOH Roselyne Bachelot provides guidelines to public sickfunds for a new drug plan	06/19/08
Pharma Express	N°274	Information to patients : the French positions at the dawn of the debates	06/17/08
Pharma Express	N°273	A new drug plan despite the non-intervention of the Health Spending Watching Committee ?	06/13/08
Pharma Express	N°272	A parliamentary report targets Medical Reps and drug evaluations, a few months before the 2009 Social Security Financing Law project	05/03/08
Pharma Express	N°271	2008 Alert Committee 2008 : Which consequences for the pharmaceutical sector?	04/23/08
Pharma Express	N°270	Regionalization, Health general assemblies, hospital : pharmaceutical challenges	04/17/08
Pharma Express	N°269	Relative effectiveness : will the SERC group change the way drugs assessment process?	03/13/08
Pharma Express	N°268	Charter of non reimbursable self-medication products : tact and cautiousness on prices	02/29/08
Pharma Express	N°267	Charter of non reimbursable selfmedication products : a charter to soften prices practices	02/27/08
Pharma Express	N°266	Woerth and Bachelot want to review taxes and drug promotion	02/13/08
Pharma Express	N°265	OTC and pharmacies : change has come	02/08/08
Pharma Express	N°264	Disease management programs : the IGAS shoots the industry again	01/24/08
Pharma Express	N°263	2008 perspectives : a key year for the industry	01/16/08
Pharma Express	N°262	The new pharmacists' margins should benefit to generic manufacturers	12/24/07
Pharma Express	N°261	Renaudin redesignated : what will be the Economic Committee's orientations?	11/28/07
Pharma Express	N°260	A Social Security Financing Law projetc drawn by the Elysée	11/22/07
Pharma Express	N°259	Social Security Financing Law project : The Senate follows the Government despite a few debates	11/16/07
Pharma Express	N°258	\"Medical reps = drug consumption\", a highly challengeable IGAS equation	11/08/07
Pharma Express	N°257	Social Security Financing Law project : The Senate will inherit the hot issues avoided by the deputees	10/30/07
Pharma Express	N°256	The Government avoids the Relative effectiveness debate	10/26/07
Pharma Express	N°255	2008 Social Security Financing Law project : The deputees symbolically debate the pharmaceutical taxes	10/25/07
Pharma Express	N°254	Social Security Financing Law project at the National Assembly : The Commission confirms the text will be nothing but a transition	10/18/07
Pharma Express	N°253	Relative effectiveness and therapeutic equivalents : do the authorities realize the consequences?	10/17/07
Pharma Express	N°252	Counterfeiting Law project : a few steps forward, but still much left to do	10/04/07
Pharma Express	N°251	2008 Social Security Financing Law project : details of the draft project for drugs	09/26/07
Pharma Express	N°250	2008 Social Security Financing Law project : « K » fixed at 1.4% and tax on sales maintained at 1%	09/24/07
Pharma Express	N°249	Public Audit Office's report : hospital and drugs accused	09/13/07
Pharma Express	N°248	The Audit Office delivers a radical point of view on drugs to the Parliament	09/05/07
Pharma Express	N°247	The new Government's drug policy still looks at financial savings	08/31/07
Pharma Express	N°246	Economic Committee 2006 report (to be published) : pressure over innovation	07/19/07
Pharma Express	N°245	Teh Government has decided to implement the Public sick funds' budget plan	07/05/07
Pharma Express	N°244	The Alert Committee strongly opposes Public sick funds	07/03/07
Pharma Express	N°243	European Pharmaceutical Forum : what perspectives for the pharmaceutical sector's competitiveness?	06/28/07
Pharma Express	N°242	Information to patients : convergence without agreement before the European Pharmaceutical Forum	06/22/07
Pharma Express	N°241	Government shuffle and plan to decrease drug expenses	06/19/07
Pharma Express	N°240	Parliament elections : apart from Dubernard, all the health leaders were reelected	06/18/07
Pharma Express	N°239	The public sick funds want to increase the drugs' contribution	06/12/07
Pharma Express	N°238	Alert Committee : 100 M€ to expect on drugs	05/29/07
Pharma Express	N°237	The Social Security piloted by the Minister of Economy from now on?	05/22/07
Pharma Express	N°236	New Government : health and Social Security still to be attributed	05/18/07
Pharma Express	N°235	Information to patients : The \"Collectif Europe & Médicament\" aggressive towards the Commission	05/10/07
Pharma Express	N°234	Presidential elections : Ségolène Royal and Nicolas Sarkozy clarify their positions on drugs	05/03/07
Pharma Express	N°233	Information to patients : the Commission opens a public consultation	04/20/07
Pharma Express	N°232	Alert Committee : despite a weak growth, drugs are still threatened	04/13/07
Pharma Express	N°231	GPs / Public sick funds agreement and Alert Committee : the alliance between Uncam and doctors threatens industry	03/22/07
Pharma Express	N°230	Elections : what should manufacturers expect	03/15/07
Pharma Express	N°229	Strategic Council for Health Industries : efforts to be maintained	02/06/07
Pharma Express	N°228	Transcription : the bicameral Commission globally adopts the Senate's version of the text	02/03/07
Pharma Express	N°227	The addendum to the 2007-2010 Framework Agreement was signed	01/30/07
Pharma Express	N°226	Transcription : the Senate delays the disease management issue after the elections	01/25/07
Pharma Express	N°225	2004/27 European Medicine Directive : a transcription far beyond Europe's ambitions	01/12/07
Pharma Express	N°224	Pharmaceutical industry : Reminding of 2006 and 2007 perspectives	01/05/07
Pharma Express	N°223	2007 Social Security Financing Law project : The Constitutionnal Council invalidates two articles on drugs	12/14/06
Pharma Express	N°222	The continue training charter just signed with the MOH	11/24/06
Pharma Express	N°221	2007 Social Security Financing Law project : In bicameral Commission confirms the Senate's positions	11/22/06
Pharma Express	N°220	2007 Social Security Financing Law project : The Senate deals with many last-minute subjects	11/16/06
Pharma Express	N°219	2007 Social Security Financing Law project : The Senate confirms the all-generics policy!	11/15/06
Pharma Express	N°218	2007 Social Security Financing Law project : very few consideration for the industry's concerns	10/31/06
Pharma Express	N°217	2007 Social Security Financing Law project : Deputees confirm the tax on sales rate (1%) as well its exceptional level	10/26/06
Pharma Express	N°216		10/26/06
Pharma Express	N°215	Hardly examined at the Parliament, the crucial pharmaceutical issues are to be delt by the Economic Committee	10/20/06
Pharma Express	N°214	Reassured by the Social Security Financing Law project and the Economic Committee's yearly orientations, the industry prorogates the Framework Agreement for 3 years	10/12/06
Pharma Express	N°213	The 2007 Social Security Financing Law draft project : articles concerning drugs	09/28/06
Pharma Express	N°212	1.8 M€ expected on drugs in 2007 but a few new measures, according to the MOH	09/27/06
Pharma Express	N°211	The MOH pleads for a conventionnal policy	09/22/06
Pharma Express	N°210	The Audit Court's position on retrocession	09/15/06
Pharma Express	N°209	Despite targetted price cuts, the industry is globally intact	09/06/06
Pharma Express	N°208	2005 Economic Committee report : expectations around more complicated market access for new products	08/04/06
Pharma Express	N°207	Pressure over Temporary MMAs endangers delays to access innovative drugs	07/12/06
Pharma Express	N°206	High Council and public sick funds : generic drugs or therapeutic equivalents?	06/22/06
Pharma Express	N°205	Addendum to Hospital Retrocession Safeguard Clause to be signed soon	06/16/06
Pharma Express	N°204	Following media pressure, the Senate's Drug Mission firmly criticizes the system without really believing it	06/15/06
Pharma Express	N°203	Medical Rep Charter guide : are you ready?	06/14/06
Pharma Express	N°202	New measures on drugs : cancelled... or postponed?	06/08/06
Pharma Express	N°201	Coming soon : New 600 M€ plan on drug expenses!	06/01/06
Pharma Express	N°200	2004/27 European Medicine Directive transposal : an opportunity for the Government to adopt other measures	05/24/06
Pharma Express	N°199	Francis Lefevre special feature : the clinical trials decree eventually published... and now?	05/05/06
Pharma Express	N°199		05/05/06
Pharma Express	N°198	Discrete and dipolmatic meeting between the Prime minister and pharmaceutical CEOs	04/18/06
Pharma Express	N°197	Discrete signature of the tripartite agreement on March 29th	04/03/06
Pharma Express	N°196	Flash : Noël Renaudin in charge of new files without leaving the Economic Committee	03/17/06
Pharma Express	N°195	Soon to be signed, does the Uncam / doctors agreement on generics open the door to therapeutic equivalents?	03/15/06
Pharma Express	N°194	Medical reps, continue training... could the State do anything without the industry?	03/03/06
Pharma Express	N°193	Generic drugs : what's behing the High Council for Healthcare system's report?	02/22/06
Pharma Express	N°192	Pressure on hospital drugs via doctors and buyers	01/20/06
Pharma Express	N°191	Substitution and margins : few constraints for the pharmacists	01/12/06
Pharma Express	N°190	Forgotten in the Finance Laws, three new taxes on clinical trials could cost a lot... in terms of attractiveness	01/10/06
Pharma Express	N°189	In 2006, will the industry avoid the renewal of 2005's scenario?	01/03/06
Pharma Express	N°188	Les failles du Rapport Pébereau entretiennent la confusion sur la part du médicament dans le déficit de la Sécurité Sociale	12/22/05
Pharma Express	N°187	Visite médicale : le CEPS avance, le HAS traine, l'industrie s'interroge…	12/12/05
Pharma Express	N°186	Convergence des prix des princeps et des génériques pour remplacer le TFR automatique	12/02/05
Pharma Express	N°185		11/22/05
Pharma Express	N°184		11/15/05
Pharma Express	N°183		11/10/05
Pharma Express	N°182		10/28/05
Pharma Express	N°181		10/20/05
Pharma Express	N°180		10/12/05
Pharma Express	N°179		10/03/05
Pharma Express	N°178		09/28/05
Pharma Express	N°177		09/16/05
Pharma Express	N°176		08/01/05
Pharma Express	N°175		07/21/05
Pharma Express	N°174		07/12/05
Pharma Express	N°173		06/28/05
Pharma Express	N°172		06/10/05
Pharma Express	N°171		06/08/05
Pharma Express	N°170		06/02/05
Pharma Express	N°169		05/26/05
Pharma Express	N°168		05/18/05
Pharma Express	N°167		05/02/05
Pharma Express	N°166		04/22/05
Pharma Express	N°165		04/15/05
Pharma Express	N°164		03/24/05
Pharma Express	N°163		03/22/05
Pharma Express	N°162		02/14/05
Pharma Express	N°161		02/10/05
Pharma Express	N°160		01/27/05
Pharma Express	N°159		01/07/05
Pharma Express	N°158	Information médicale, quel rôle pour l'industrie... et pour l'Etat ?	12/14/04
Pharma Express	N°157	Le Gouvernement souffle le chaud et le froid sur la pharma	11/25/04
Pharma Express	N°156	Au Brésil, Douste-Blazy annonce que la France transposera bientôt les dispositions de Doha sur les licences obligatoires	10/15/04
Pharma Express	N°155		10/06/04
Pharma Express	N°154		10/04/04
Pharma Express	N°153		09/22/04
Pharma Express	N°152		09/17/04
Pharma Express	N°151		09/15/04
Pharma Express	N°150		09/02/04
Pharma Express	N°149		08/26/04
Pharma Express	N°148		07/27/04
Pharma Express	N°147		07/20/04
Pharma Express	N°146		06/29/04
Pharma Express	N°145		06/16/04
Pharma Express	N°144		06/11/04
Pharma Express	N°143		06/02/04
Pharma Express	N°142		05/19/04
Pharma Express	N°141		05/07/04
Pharma Express	N°140		04/29/04
Pharma Express	N°139		04/16/04
Pharma Express	N°138		04/15/04
Pharma Express	N°137		04/05/04
Pharma Express	N°136		03/31/04
Pharma Express	N°135		03/30/04
Pharma Express	N°134		02/19/04
Pharma Express	N°133		02/09/04
Pharma Express	N°132		01/26/04
Pharma Express	N°131		01/16/04
Pharma Express	N°130		01/15/04
Pharma Express	N°129		01/14/04
Pharma Express	N°128	L’étude Masson, rendue publique hier, sera-t-elle suivie d’actes ?	12/12/03
Pharma Express	N°127	Flash : le Conseil Constitutionnel invalide la sécurisation de certains versements de la taxe promo – bilan de la LFSS 2004	12/12/03
Pharma Express	N°126		12/10/03
Pharma Express	N°125		11/29/03
Pharma Express	N°124		11/19/03
Pharma Express	N°123		10/30/03
Pharma Express	N°122		10/23/03
Pharma Express	N°121		10/09/03
Pharma Express	N°120		09/25/03
Pharma Express	N°119		09/19/03
Pharma Express	N°118		09/05/03
Pharma Express	N°117		09/01/03
Pharma Express	N°116		07/17/03
Pharma Express	N°115		06/27/03
Pharma Express	N°114		06/16/03
Pharma Express	N°113		06/12/03
Pharma Express	N°112		05/28/03
Pharma Express	N°111		05/22/03
Pharma Express	N°110		05/14/03
Pharma Express	N°109		05/06/03
Pharma Express	N°108		04/23/03
Pharma Express	N°107		04/11/03
Pharma Express	N°106		04/10/03
Pharma Express	N°105		03/28/03
Pharma Express	N°104		03/12/03
Pharma Express	N°103		01/30/03
Pharma Express	N°102		01/28/03
Pharma Express	N°101		01/09/03
Pharma Express	N°100		01/07/03
Pharma Express	N°99	Le conseil constitutionnel place le forfait de remboursement sous surveillance	12/18/02
Pharma Express	N°98	42ème version du décret « rétrocession » !!!	12/16/02
Pharma Express	N°97		11/28/02
Pharma Express	N°96		11/22/02
Pharma Express	N°95		11/20/02
Pharma Express	N°94		10/31/02
Pharma Express	N°93		10/29/02
Pharma Express	N°92		10/10/02
Pharma Express	N°91		10/09/02
Pharma Express	N°90		10/07/02
Pharma Express	N°89		09/24/02
Pharma Express	N°88		09/19/02
Pharma Express	N°87		09/18/02
Pharma Express	N°86		09/06/02
Pharma Express	N°85		07/15/02
Pharma Express	N°84		07/09/02
Pharma Express	N°83		06/27/02
Pharma Express	N°82		06/18/02
Pharma Express	N°81		05/24/02
Pharma Express	N°80		04/24/02
Pharma Express	N°79		04/15/02
Pharma Express	N°78		03/20/02
Pharma Express	N°77		02/14/02
Pharma Express	N°76		02/07/02
Pharma Express	N°75		02/01/02
Pharma Express	N°73		01/21/02
Pharma Express	N°72		01/11/02
Pharma Express	N°71		12/10/01
Pharma Express	N°70		12/03/01
Pharma Express	N°69		11/21/01
Pharma Express	N°68		11/16/01
Pharma Express	N°67		10/20/01
Pharma Express	N°66		09/27/01
Pharma Express	N°65		09/14/01
Pharma Express	N°64		09/03/01
Pharma Express	N°63		07/30/01
Pharma Express	N°62		07/20/01
Pharma Express	N°61		07/13/01
Pharma Express	N°60		07/09/01
Pharma Express	N°59		06/05/01
Pharma Express	N°58		05/17/01
Pharma Express	N°57		05/09/01
Pharma Express	N°56		05/02/01
Pharma Express	N°55		04/23/01
Pharma Express	N°54		03/19/01
Pharma Express	N°53		03/05/01
Pharma Express	N°52		02/19/01
Pharma Express	N°51		02/06/01
Pharma Express	N°50		02/06/01
Pharma Express	N°49		02/05/01
Pharma Express	N°48		01/28/01
Pharma Express	N°47		01/25/01
Pharma Express	N°74		01/23/01
Pharma Express	N°46		01/18/01
Pharma Express	N°45		01/15/01

List of Pharma Express Jurisprudence

Pharma Express Jurisprudence	N°70	Arrêt Cephalon (baisse de remboursement)	04/27/12
Pharma Express Jurisprudence	N°70	Arrêt Biotronik (taxes DM)	04/27/12
Pharma Express Jurisprudence	N°59	Nouvelle étape dans la bataille qui oppose Leclerc aux pharmaciens	05/15/11
Pharma Express Jurisprudence	N°59	HAS : Une recommandation annulée pour cause de conflits d’intérêt	05/15/11
Pharma Express Jurisprudence	N°58	Le Conseil d'Etat valide les CAPI	04/15/11
Pharma Express Jurisprudence	N°58	Hors-AMM : Une analyse à géométrie variable	04/15/11
Pharma Express Jurisprudence	N°57	Novartis : Précision de la notion d’atteinte imminente aux droits de propriété dans le cadre d’un CCP	03/14/11
Pharma Express Jurisprudence	N°57	Expanscience : Les objets promotionnels concernés par la taxe promotionnelle	03/14/11
Pharma Express Jurisprudence	N°56	Arrêts Medipha (procédure abrégée) et Hépatite B (responsabilité)	02/09/11
Pharma Express Jurisprudence	N°55	Arrêt Teofarma (refus hausse de prix) et Cephalon (Publicité comparative)	12/17/10
Pharma Express Jurisprudence	N°54	Arrêts Catalgine (responsabilité du prescripteur) et Pfizer (inscription liste en sus)	11/21/10
Pharma Express Jurisprudence	N°53	Arrêts CSL Behring (désignation orpheline) et BMS & autres (taxe ventes directes)	10/18/10
Pharma Express Jurisprudence	N°50	What are the limits to protect against the arrival of generics in France?	06/21/10
Pharma Express Jurisprudence	N°50	Still difficult to contest a Transparency Committee opinion	06/21/10
Pharma Express Jurisprudence	N°49	Hépatite B : Des raccourcis pour établir le lien avec le vaccin	05/25/10
Pharma Express Jurisprudence	N°49	ABPI : EU Court recognizes ability for States to incitate generic prescriptions	05/25/10
Pharma Express Jurisprudence	N°48	DocMorris : Quelles contraintes pour la vente en ligne de médicaments	04/26/10
Pharma Express Jurisprudence	N°48	AGIM : Les Etats confortés sur la fixation du prix des médicaments	04/26/10
Pharma Express Jurisprudence	N°47	AVENTIS : DONNER DES PRODUITS A L’HÔPITAL N’EST PAS FORCEMMENT ANTICONCURRENTIEL	03/24/10
Pharma Express Jurisprudence	N°47	ABPI : LES INCITATIONS À PRESCRIRE DES GÉNÉRIQUES BIENTÔT ILLÉGALES ?	03/24/10
Pharma Express Jurisprudence	N°46	MENARINI : LE JUGE REPREND L’AFFSAPS SUR LA RÉEVALUATION DU RISQUE	03/12/10
Pharma Express Jurisprudence	N°46	ADDMEDICA : À QUAND LA POSSIBILITÉ DE FAIRE APPEL DES AVIS DE TRANSPARENCE ?	03/12/10
Pharma Express Jurisprudence	N°45	Schering-Plough : Santé publique et assurance-maladie evoquées sur des questions de concurrence	12/28/09
Pharma Express Jurisprudence	N°45	PLFSS : le Conseil constitutionnel censure le « dual pricing » et la notion élargie de générique	12/28/09
Pharma Express Jurisprudence	N°44	Sandoz: Can generic drugmaker use the brandname?	11/14/09
Pharma Express Jurisprudence	N°44	AHP : Souplesse sur l'octroi de plusieurs CCP	11/13/09
Pharma Express Jurisprudence	N°43	Servier : Le CEPS en arbitre des décisions de l'AFSSAPS sur la publicité	08/07/09
Pharma Express Jurisprudence	N°43	Di-Antalvic : Pourquoi appliquer le retrait en France ?	08/07/09
Pharma Express Jurisprudence	N°42	CJCE : Toute information (positive) sur un médicament peut s'apparenter à une publicité	06/26/09
Pharma Express Jurisprudence	N°42	CJCE : Les Etats peuvent restreindre la détention d'officines aux seuls pharmaciens	06/26/09
Pharma Express Jurisprudence	N°41	GSK : Sales at a lower price is not enough to be an abuse of power market	05/25/09
Pharma Express Jurisprudence	N°41	Distilbène : Victims take advantage on doubt	05/25/09
Pharma Express Jurisprudence	N°40	SANOFI PHARMA BMS : Good Practices Agreements do not have to care about products efficacity	03/30/09
Pharma Express Jurisprudence	N°40	NEGMA : The generic drugs' battle is increasing ... outside of the Courts	03/30/09
Pharma Express Jurisprudence	N°39	GSK : Precisions on repackaging solutions for parallel importations	02/16/09
Pharma Express Jurisprudence	N°39	BAXTER : Judges change their mind about responsability of the blood products producers	02/16/09
Pharma Express Jurisprudence	N°38	Synthon: Mutual recognition as generic labs' Trojan Horse	01/14/09
Pharma Express Jurisprudence	N°38	Social Security Financing Bill 2009: Nineteen social riders censured by the Constitutionnal Council	01/14/09
Pharma Express Jurisprudence	N°37	LEEM : expenditures regulation before freedom of competition	11/15/08
Pharma Express Jurisprudence	N°36	GSK & PFIZER : Will the medical visits' quotats end ?	10/15/08
Pharma Express Jurisprudence	N°35	Mosaïque : duration of depreciations non determined	09/15/08
Pharma Express Jurisprudence	N°34	GSK : hard implementation of tje responsabilisation by the Court of Cassation	07/15/08
Pharma Express Jurisprudence	N°31	Reckitt Benckiser Healthcare : Generics bioequivalence well confirmed	04/15/08
Pharma Express Jurisprudence	N°31	Mayoli & Novartis : What are the Economic Committee's powers after a advertisement ban?	04/15/08
Pharma Express Jurisprudence	N°32	GSK : Will the principle of quotats as a limitation of parallel trade be accepted ?	04/15/08
Pharma Express Jurisprudence	N°30	Social Security Financing Law : The Constitutionnal Board validates the user-fee measure	01/30/08
Pharma Express Jurisprudence	N°30	Schering-Plough : Public health and Social Security mentionned for rivalty issues	01/30/08
Pharma Express Jurisprudence	N°29	CRCI : How are fixed the indemnisation rates due to therapeutic risks and how to oppose them	12/15/07
Pharma Express Jurisprudence	N°29	AstraZeneca : What is the generic manufacturer allowed to with the brand name?	12/15/07
Pharma Express Jurisprudence	N°28	UCB/Novartis : Crucial criteria to engage the manufacturers' responsibility	10/15/07
Pharma Express Jurisprudence	N°28	MSD : How far to go to win a trial?	10/15/07
Pharma Express Jurisprudence	N°27	OM Pharma : How to distinguish benefit/risk assessment and precautionary principle for an MMA suppression?	09/15/07
Pharma Express Jurisprudence	N°27	FHP : Towards a complicated renewal of the drug agreements in hospitals	09/15/07
Pharma Express Jurisprudence	N°26	Rivalty : Curtailment framed to limit parallel trade	08/15/07
Pharma Express Jurisprudence	N°26	Biocodex : Hard to oppose the MOH's will to stop reimbursing a drug	08/15/07
Pharma Express Jurisprudence	N°25	GSK : A decision by the Economic Committee calls into question the generic manufacturers' advantage on margins	07/15/07
Pharma Express Jurisprudence	N°25	Boehringer : The European Court limits the importator's repackaging rights	07/15/07
Pharma Express Jurisprudence	N°24	GSK : A new step towards the reimbursement of the tax on direct sales	06/15/07
Pharma Express Jurisprudence	N°24	G. GAM : Pfizer's strategy to prorogate a patent rejected	06/15/07
Pharma Express Jurisprudence	N°23	Joly&Jatel : Formerly reimbursed drugs cannot come back to being reimbursed unless crucial irregularities have been noticed	04/15/07
Pharma Express Jurisprudence	N°23	GSK : Condamnation for predatory prices limiting generics' access to market	04/15/07
Pharma Express Jurisprudence	N°22	LEEM : No changes to the regulation regarding advertising of formerly reimbursed drugs	02/15/07
Pharma Express Jurisprudence	N°22	Actelion : The Economic Committee as strong on the hospital as on the retail market	02/15/07
Pharma Express Jurisprudence	N°21	Fenioux : The drug definition is crucial to deposit a MMA dossier or not	01/15/07
Pharma Express Jurisprudence	N°21	Chiesi : France condamned for having lowered reimbursements	01/15/07
Pharma Express Jurisprudence	N°20		12/15/06
Pharma Express Jurisprudence	N°20		12/15/06
Pharma Express Jurisprudence	N°19		11/15/06
Pharma Express Jurisprudence	N°19		11/15/06
Pharma Express Jurisprudence	N°18		10/15/06
Pharma Express Jurisprudence	N°18		10/15/06
Pharma Express Jurisprudence	N°17		08/15/06
Pharma Express Jurisprudence	N°17		08/15/06
Pharma Express Jurisprudence	N°16		06/15/06
Pharma Express Jurisprudence	N°16		06/15/06
Pharma Express Jurisprudence	N°15		05/15/06
Pharma Express Jurisprudence	N°15		05/15/06
Pharma Express Jurisprudence	N°14		04/15/06
Pharma Express Jurisprudence	N°14		04/15/06
Pharma Express Jurisprudence	N°13		03/15/06
Pharma Express Jurisprudence	N°13		03/15/06
Pharma Express Jurisprudence	N°11		01/15/06
Pharma Express Jurisprudence	N°11		01/15/06
Pharma Express Jurisprudence	N°10		12/15/05
Pharma Express Jurisprudence	N°10		12/15/05
Pharma Express Jurisprudence	N°9		11/15/05
Pharma Express Jurisprudence	N°9		11/15/05
Pharma Express Jurisprudence	N°8		10/15/05
Pharma Express Jurisprudence	N°8		10/15/05
Pharma Express Jurisprudence	N°7		09/15/05
Pharma Express Jurisprudence	N°7		09/15/05
Pharma Express Jurisprudence	N°6		08/15/05
Pharma Express Jurisprudence	N°6		08/15/05
Pharma Express Jurisprudence	N°5		07/15/05
Pharma Express Jurisprudence	N°5		07/15/05
Pharma Express Jurisprudence	N°4		06/15/05
Pharma Express Jurisprudence	N°4		06/15/05
Pharma Express Jurisprudence	N°3		05/15/05
Pharma Express Jurisprudence	N°3		05/15/05
Pharma Express Jurisprudence	N°2		04/15/05
Pharma Express Jurisprudence	N°2		04/15/05
Pharma Express Jurisprudence	N°1		03/15/05
Pharma Express Jurisprudence	N°1		03/15/05
Pharma Express Jurisprudence	N°0		02/15/05
Pharma Express Jurisprudence	N°0		02/15/05
Pharma Express Jurisprudence	N°0		02/15/05

List of Pharma Express International

Pharma Express International	N°29	April 2012	04/26/12
Pharma Express International	N°26	January 2012	01/15/12
Pharma Express International	N°18	Avril-Mai 2011	05/20/11
Pharma Express International	N°15	Pharma Express International n°15 - January 2011	02/15/11
Pharma Express International	N°14	Pharma Express International n°14 - December 2010	01/06/11
Pharma Express International	N°13	Pharma Express International n°13 - November 2010	12/07/10
Pharma Express International	N°12	September/October 2010	10/22/10
Pharma Express International	N°7	Financial crisis and regulation measures, amendments to EU pharmaceutical package, MA delays in Japan...	05/12/10
Pharma Express International	N°4	Reference price and prescription regulation in Spain, UK lifesciences super-cluster, EMEA Roadmap, EU pharmaceutical package...	02/17/10
Pharma Express International	N°3	Price level in the UK, beginning of the cost-benefit assessment in Germany, European patent, Japanese biotech plan...	01/15/10
Pharma Express International	N°2	US and German healthcare bills, new EU Commission, price cuts in China...	01/13/10
Pharma Express International	N°1	German cost-benefit assessment, UK pharma innovation plan, drug consumption in Italy, EU pharmaceutical package, patents in Brazil, US R&D productivity, counterfeiting ...	10/29/09

List of «Opinions Santé»

List of news